Wells Fargo’s Unity Biotechnology UBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12 Hold
31
﹤0.01% 6429
2025
Q1
$32 Hold
31
﹤0.01% 6078
2024
Q4
$30 Sell
31
-30
-49% -$29 ﹤0.01% 6106
2024
Q3
$90 Sell
61
-43,341
-100% -$63.9K ﹤0.01% 5881
2024
Q2
$58.6K Sell
43,402
-119
-0.3% -$161 ﹤0.01% 4870
2024
Q1
$71.4K Buy
43,521
+17
+0% +$28 ﹤0.01% 4713
2023
Q4
$84K Buy
43,504
+5
+0% +$10 ﹤0.01% 4603
2023
Q3
$104K Buy
43,499
+2
+0% +$5 ﹤0.01% 4419
2023
Q2
$111K Buy
43,497
+43,346
+28,706% +$111K ﹤0.01% 4709
2023
Q1
$247 Sell
151
-1
-0.7% -$2 ﹤0.01% 6395
2022
Q4
$416 Buy
152
+49
+48% +$134 ﹤0.01% 6104
2022
Q3
$0 Sell
103
-6
-6% ﹤0.01% 7054
2022
Q2
$0 Sell
109
-13
-11% ﹤0.01% 7172
2022
Q1
$2K Buy
122
+20
+20% +$328 ﹤0.01% 6349
2021
Q4
$1K Buy
102
+21
+26% +$206 ﹤0.01% 6522
2021
Q3
$2K Hold
81
﹤0.01% 6263
2021
Q2
$4K Sell
81
-909
-92% -$44.9K ﹤0.01% 6075
2021
Q1
$60K Sell
990
-5,552
-85% -$336K ﹤0.01% 5388
2020
Q4
$343K Buy
6,542
+4,474
+216% +$235K ﹤0.01% 4691
2020
Q3
$71K Sell
2,068
-11,992
-85% -$412K ﹤0.01% 5168
2020
Q2
$1.22M Buy
14,060
+11,925
+559% +$1.03M ﹤0.01% 3575
2020
Q1
$124K Buy
2,135
+478
+29% +$27.8K ﹤0.01% 4769
2019
Q4
$119K Buy
1,657
+7
+0.4% +$503 ﹤0.01% 5021
2019
Q3
$101K Buy
1,650
+110
+7% +$6.73K ﹤0.01% 5083
2019
Q2
$147K Buy
1,540
+95
+7% +$9.07K ﹤0.01% 4929
2019
Q1
$118K Sell
1,445
-1,850
-56% -$151K ﹤0.01% 4997
2018
Q4
$536K Buy
3,295
+3,061
+1,308% +$498K ﹤0.01% 4167
2018
Q3
$38K Buy
234
+152
+185% +$24.7K ﹤0.01% 5367
2018
Q2
$12K Buy
+82
New +$12K ﹤0.01% 5573